[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Viral Vector and Plasmid DNA Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

July 2023 | 121 pages | ID: G1DA4A9F4077EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question


Viral vector and plasmid DNA are tools to transfer genetic material into cells. Viral vectors are generally utilized as vectors for gene therapy.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Viral Vector and Plasmid DNA market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Viral Vector and Plasmid DNA market are covered in Chapter 9:

Waisman Biomanufacturing
Aldevron
Creative Biogene
uniQure N.V.
Cobra Biologics
Merck
Addgene
Novasep
The Cell and Gene Therapy Catapult

In Chapter 5 and Chapter 7.3, based on types, the Viral Vector and Plasmid DNA market from 2017 to 2027 is primarily split into:

Plasmid DNA
Viral Vector


In Chapter 6 and Chapter 7.4, based on applications, the Viral Vector and Plasmid DNA market from 2017 to 2027 covers:

Cancer
Virus Infection
Hereditary Disease

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Viral Vector and Plasmid DNA market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Viral Vector and Plasmid DNA Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 VIRAL VECTOR AND PLASMID DNA MARKET OVERVIEW

1.1 Product Overview and Scope of Viral Vector and Plasmid DNA Market
1.2 Viral Vector and Plasmid DNA Market Segment by Type
  1.2.1 Global Viral Vector and Plasmid DNA Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Viral Vector and Plasmid DNA Market Segment by Application
  1.3.1 Viral Vector and Plasmid DNA Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Viral Vector and Plasmid DNA Market, Region Wise (2017-2027)
  1.4.1 Global Viral Vector and Plasmid DNA Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Viral Vector and Plasmid DNA Market Status and Prospect (2017-2027)
  1.4.3 Europe Viral Vector and Plasmid DNA Market Status and Prospect (2017-2027)
  1.4.4 China Viral Vector and Plasmid DNA Market Status and Prospect (2017-2027)
  1.4.5 Japan Viral Vector and Plasmid DNA Market Status and Prospect (2017-2027)
  1.4.6 India Viral Vector and Plasmid DNA Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Viral Vector and Plasmid DNA Market Status and Prospect (2017-2027)
  1.4.8 Latin America Viral Vector and Plasmid DNA Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Viral Vector and Plasmid DNA Market Status and Prospect (2017-2027)
1.5 Global Market Size of Viral Vector and Plasmid DNA (2017-2027)
  1.5.1 Global Viral Vector and Plasmid DNA Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Viral Vector and Plasmid DNA Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Viral Vector and Plasmid DNA Market

2 INDUSTRY OUTLOOK

2.1 Viral Vector and Plasmid DNA Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Viral Vector and Plasmid DNA Market Drivers Analysis
2.4 Viral Vector and Plasmid DNA Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Viral Vector and Plasmid DNA Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Viral Vector and Plasmid DNA Industry Development

3 GLOBAL VIRAL VECTOR AND PLASMID DNA MARKET LANDSCAPE BY PLAYER

3.1 Global Viral Vector and Plasmid DNA Sales Volume and Share by Player (2017-2022)
3.2 Global Viral Vector and Plasmid DNA Revenue and Market Share by Player (2017-2022)
3.3 Global Viral Vector and Plasmid DNA Average Price by Player (2017-2022)
3.4 Global Viral Vector and Plasmid DNA Gross Margin by Player (2017-2022)
3.5 Viral Vector and Plasmid DNA Market Competitive Situation and Trends
  3.5.1 Viral Vector and Plasmid DNA Market Concentration Rate
  3.5.2 Viral Vector and Plasmid DNA Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL VIRAL VECTOR AND PLASMID DNA SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Viral Vector and Plasmid DNA Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Viral Vector and Plasmid DNA Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Viral Vector and Plasmid DNA Market Under COVID-19
4.5 Europe Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Viral Vector and Plasmid DNA Market Under COVID-19
4.6 China Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Viral Vector and Plasmid DNA Market Under COVID-19
4.7 Japan Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Viral Vector and Plasmid DNA Market Under COVID-19
4.8 India Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Viral Vector and Plasmid DNA Market Under COVID-19
4.9 Southeast Asia Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Viral Vector and Plasmid DNA Market Under COVID-19
4.10 Latin America Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Viral Vector and Plasmid DNA Market Under COVID-19
4.11 Middle East and Africa Viral Vector and Plasmid DNA Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Viral Vector and Plasmid DNA Market Under COVID-19

5 GLOBAL VIRAL VECTOR AND PLASMID DNA SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Viral Vector and Plasmid DNA Sales Volume and Market Share by Type (2017-2022)
5.2 Global Viral Vector and Plasmid DNA Revenue and Market Share by Type (2017-2022)
5.3 Global Viral Vector and Plasmid DNA Price by Type (2017-2022)
5.4 Global Viral Vector and Plasmid DNA Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Viral Vector and Plasmid DNA Sales Volume, Revenue and Growth Rate of Plasmid DNA (2017-2022)
  5.4.2 Global Viral Vector and Plasmid DNA Sales Volume, Revenue and Growth Rate of Viral Vector (2017-2022)

6 GLOBAL VIRAL VECTOR AND PLASMID DNA MARKET ANALYSIS BY APPLICATION

6.1 Global Viral Vector and Plasmid DNA Consumption and Market Share by Application (2017-2022)
6.2 Global Viral Vector and Plasmid DNA Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Viral Vector and Plasmid DNA Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Viral Vector and Plasmid DNA Consumption and Growth Rate of Cancer (2017-2022)
  6.3.2 Global Viral Vector and Plasmid DNA Consumption and Growth Rate of Virus Infection (2017-2022)
  6.3.3 Global Viral Vector and Plasmid DNA Consumption and Growth Rate of Hereditary Disease (2017-2022)

7 GLOBAL VIRAL VECTOR AND PLASMID DNA MARKET FORECAST (2022-2027)

7.1 Global Viral Vector and Plasmid DNA Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Viral Vector and Plasmid DNA Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Viral Vector and Plasmid DNA Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Viral Vector and Plasmid DNA Price and Trend Forecast (2022-2027)
7.2 Global Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Viral Vector and Plasmid DNA Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Viral Vector and Plasmid DNA Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Viral Vector and Plasmid DNA Revenue and Growth Rate of Plasmid DNA (2022-2027)
  7.3.2 Global Viral Vector and Plasmid DNA Revenue and Growth Rate of Viral Vector (2022-2027)
7.4 Global Viral Vector and Plasmid DNA Consumption Forecast by Application (2022-2027)
  7.4.1 Global Viral Vector and Plasmid DNA Consumption Value and Growth Rate of Cancer(2022-2027)
  7.4.2 Global Viral Vector and Plasmid DNA Consumption Value and Growth Rate of Virus Infection(2022-2027)
  7.4.3 Global Viral Vector and Plasmid DNA Consumption Value and Growth Rate of Hereditary Disease(2022-2027)
7.5 Viral Vector and Plasmid DNA Market Forecast Under COVID-19

8 VIRAL VECTOR AND PLASMID DNA MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Viral Vector and Plasmid DNA Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Viral Vector and Plasmid DNA Analysis
8.6 Major Downstream Buyers of Viral Vector and Plasmid DNA Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Viral Vector and Plasmid DNA Industry

9 PLAYERS PROFILES

9.1 Waisman Biomanufacturing
  9.1.1 Waisman Biomanufacturing Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.1.3 Waisman Biomanufacturing Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Aldevron
  9.2.1 Aldevron Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.2.3 Aldevron Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Creative Biogene
  9.3.1 Creative Biogene Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.3.3 Creative Biogene Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 uniQure N.V.
  9.4.1 uniQure N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.4.3 uniQure N.V. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Cobra Biologics
  9.5.1 Cobra Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.5.3 Cobra Biologics Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Merck
  9.6.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.6.3 Merck Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Addgene
  9.7.1 Addgene Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.7.3 Addgene Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Novasep
  9.8.1 Novasep Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.8.3 Novasep Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 The Cell and Gene Therapy Catapult
  9.9.1 The Cell and Gene Therapy Catapult Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Viral Vector and Plasmid DNA Product Profiles, Application and Specification
  9.9.3 The Cell and Gene Therapy Catapult Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Viral Vector and Plasmid DNA Product Picture
Table Global Viral Vector and Plasmid DNA Market Sales Volume and CAGR (%) Comparison by Type
Table Viral Vector and Plasmid DNA Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Viral Vector and Plasmid DNA Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Viral Vector and Plasmid DNA Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Viral Vector and Plasmid DNA Industry Development
Table Global Viral Vector and Plasmid DNA Sales Volume by Player (2017-2022)
Table Global Viral Vector and Plasmid DNA Sales Volume Share by Player (2017-2022)
Figure Global Viral Vector and Plasmid DNA Sales Volume Share by Player in 2021
Table Viral Vector and Plasmid DNA Revenue (Million USD) by Player (2017-2022)
Table Viral Vector and Plasmid DNA Revenue Market Share by Player (2017-2022)
Table Viral Vector and Plasmid DNA Price by Player (2017-2022)
Table Viral Vector and Plasmid DNA Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Viral Vector and Plasmid DNA Sales Volume, Region Wise (2017-2022)
Table Global Viral Vector and Plasmid DNA Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Viral Vector and Plasmid DNA Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Viral Vector and Plasmid DNA Sales Volume Market Share, Region Wise in 2021
Table Global Viral Vector and Plasmid DNA Revenue (Million USD), Region Wise (2017-2022)
Table Global Viral Vector and Plasmid DNA Revenue Market Share, Region Wise (2017-2022)
Figure Global Viral Vector and Plasmid DNA Revenue Market Share, Region Wise (2017-2022)
Figure Global Viral Vector and Plasmid DNA Revenue Market Share, Region Wise in 2021
Table Global Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Viral Vector and Plasmid DNA Sales Volume by Type (2017-2022)
Table Global Viral Vector and Plasmid DNA Sales Volume Market Share by Type (2017-2022)
Figure Global Viral Vector and Plasmid DNA Sales Volume Market Share by Type in 2021
Table Global Viral Vector and Plasmid DNA Revenue (Million USD) by Type (2017-2022)
Table Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2017-2022)
Figure Global Viral Vector and Plasmid DNA Revenue Market Share by Type in 2021
Table Viral Vector and Plasmid DNA Price by Type (2017-2022)
Figure Global Viral Vector and Plasmid DNA Sales Volume and Growth Rate of Plasmid DNA (2017-2022)
Figure Global Viral Vector and Plasmid DNA Revenue (Million USD) and Growth Rate of Plasmid DNA (2017-2022)
Figure Global Viral Vector and Plasmid DNA Sales Volume and Growth Rate of Viral Vector (2017-2022)
Figure Global Viral Vector and Plasmid DNA Revenue (Million USD) and Growth Rate of Viral Vector (2017-2022)
Table Global Viral Vector and Plasmid DNA Consumption by Application (2017-2022)
Table Global Viral Vector and Plasmid DNA Consumption Market Share by Application (2017-2022)
Table Global Viral Vector and Plasmid DNA Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Viral Vector and Plasmid DNA Consumption Revenue Market Share by Application (2017-2022)
Table Global Viral Vector and Plasmid DNA Consumption and Growth Rate of Cancer (2017-2022)
Table Global Viral Vector and Plasmid DNA Consumption and Growth Rate of Virus Infection (2017-2022)
Table Global Viral Vector and Plasmid DNA Consumption and Growth Rate of Hereditary Disease (2017-2022)
Figure Global Viral Vector and Plasmid DNA Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Viral Vector and Plasmid DNA Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Viral Vector and Plasmid DNA Price and Trend Forecast (2022-2027)
Figure USA Viral Vector and Plasmid DNA Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Viral Vector and Plasmid DNA Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Viral Vector and Plasmid DNA Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Viral Vector and Plasmid DNA Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Viral Vector and Plasmid DNA Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Viral Vector and Plasmid DNA Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Viral Vector and Plasmid DNA Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Viral Vector and Plasmid DNA Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Viral Vector and Plasmid DNA Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Viral Vector and Plasmid DNA Market Sales Volume Forecast, by Type
Table Global Viral Vector and Plasmid DNA Sales Volume Market Share Forecast, by Type
Table Global Viral Vector and Plasmid DNA Market Revenue (Million USD) Forecast, by Type
Table Global Viral Vector and Plasmid DNA Revenue Market Share Forecast, by Type
Table Global Viral Vector and Plasmid DNA Price Forecast, by Type
Figure Global Viral Vector and Plasmid DNA Revenue (Million USD) and Growth Rate of Plasmid DNA (2022-2027)
Figure Global Viral Vector and Plasmid DNA Revenue (Million USD) and Growth Rate of Plasmid DNA (2022-2027)
Figure Global Viral Vector and Plasmid DNA Revenue (Million USD) and Growth Rate of Viral Vector (2022-2027)
Figure Global Viral Vector and Plasmid DNA Revenue (Million USD) and Growth Rate of Viral Vector (2022-2027)
Table Global Viral Vector and Plasmid DNA Market Consumption Forecast, by Application
Table Global Viral Vector and Plasmid DNA Consumption Market Share Forecast, by Application
Table Global Viral Vector and Plasmid DNA Market Revenue (Million USD) Forecast, by Application
Table Global Viral Vector and Plasmid DNA Revenue Market Share Forecast, by Application
Figure Global Viral Vector and Plasmid DNA Consumption Value (Million USD) and Growth Rate of Cancer (2022-2027)
Figure Global Viral Vector and Plasmid DNA Consumption Value (Million USD) and Growth Rate of Virus Infection (2022-2027)
Figure Global Viral Vector and Plasmid DNA Consumption Value (Million USD) and Growth Rate of Hereditary Disease (2022-2027)
Figure Viral Vector and Plasmid DNA Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Waisman Biomanufacturing Profile
Table Waisman Biomanufacturing Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Waisman Biomanufacturing Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure Waisman Biomanufacturing Revenue (Million USD) Market Share 2017-2022
Table Aldevron Profile
Table Aldevron Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aldevron Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure Aldevron Revenue (Million USD) Market Share 2017-2022
Table Creative Biogene Profile
Table Creative Biogene Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Creative Biogene Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure Creative Biogene Revenue (Million USD) Market Share 2017-2022
Table uniQure N.V. Profile
Table uniQure N.V. Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure uniQure N.V. Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure uniQure N.V. Revenue (Million USD) Market Share 2017-2022
Table Cobra Biologics Profile
Table Cobra Biologics Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cobra Biologics Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure Cobra Biologics Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Addgene Profile
Table Addgene Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Addgene Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure Addgene Revenue (Million USD) Market Share 2017-2022
Table Novasep Profile
Table Novasep Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novasep Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure Novasep Revenue (Million USD) Market Share 2017-2022
Table The Cell and Gene Therapy Catapult Profile
Table The Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure The Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Sales Volume and Growth Rate
Figure The Cell and Gene Therapy Catapult Revenue (Million USD) Market Share 2017-2022


More Publications